Breast Cancer
Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
Published in Women's Health Weekly, December 25th, 2008
Genomic Health, Inc. (NASDAQ:GHDX) announced findings from a European study demonstrating that the Oncotype DX Recurrence Score(R) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive breast cancer patients who are treated with the aromatase inhibitor anastrozole or with tamoxifen. Researchers from the Royal Marsden Hospital in London discussed results today in an oral presentation at the 31st Annual San Antonio Breast Cancer Symposium.
Oncotype DX is a multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit as well as the likelihood of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Albert Einstein College of Medicine
Einstein researchers discover protein that contributes to cancer spread - American Association for Cancer Research
Selenium may prevent high risk-bladder cancer - Catholic University
A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart - JAMA and Archives Journals
Neither vitamin C or E associated with reduced risk of prostate cancer, or other cancers - Journal of the National Cancer Institute
Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer - McGill University Health Centre
Lack of vitamin D causes weight gain and stunts growth in girls - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
